Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/148013
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Finder, Stuart G. | |
dc.contributor.author | Bliton, Mark J. | |
dc.date.accessioned | 2022-05-03T09:54:35Z | - |
dc.date.available | 2022-05-03T09:54:35Z | - |
dc.date.issued | 2018 | |
dc.identifier.isbn | 9783319909554 | |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/148013 | - |
dc.language.iso | eng | |
dc.publisher | Springer | |
dc.relation.isbasedon | 10.1007/978-3-319-90955-4 | |
dc.relation.uri | https://library.oapen.org/bitstream/20.500.12657/22936/1/1007225.pdf | |
dc.rights.uri | CC BY-NC-ND (姓名標示-非商業性-禁止改作) | |
dc.source | DOAB | |
dc.subject.classification | Medicine | |
dc.subject.other | cinnamic acid derivatives | |
dc.subject.other | soybean seed ferritin | |
dc.subject.other | iron release | |
dc.subject.other | binding ability | |
dc.subject.other | Fe2+-chelating activity | |
dc.subject.other | reducibility | |
dc.subject.other | adverse event profile | |
dc.subject.other | anaemia | |
dc.subject.other | bioengineering | |
dc.subject.other | labile iron | |
dc.subject.other | intravenous iron | |
dc.subject.other | iron-carbohydrate complex | |
dc.subject.other | iron processing | |
dc.subject.other | iron metabolism | |
dc.subject.other | infection | |
dc.subject.other | innate immunity | |
dc.subject.other | hepcidin | |
dc.subject.other | ferritin | |
dc.subject.other | anemia of inflammation | |
dc.subject.other | pharmaceutical targets | |
dc.subject.other | iron deficiency anemia | |
dc.subject.other | nutrient iron | |
dc.subject.other | oral iron therapy | |
dc.subject.other | FeSO4 | |
dc.subject.other | NaFeEDTA | |
dc.subject.other | non-transferrin-bound iron (NTBI) | |
dc.subject.other | developing countries | |
dc.subject.other | Indonesia | |
dc.subject.other | neurodegeneration | |
dc.subject.other | mitochondria | |
dc.subject.other | therapy | |
dc.subject.other | heme | |
dc.subject.other | haem | |
dc.subject.other | Iron-sulfur | |
dc.subject.other | Friedreich Ataxia | |
dc.subject.other | Oxidative stress | |
dc.subject.other | Iron chelators | |
dc.subject.other | iron deficiency | |
dc.subject.other | anemia | |
dc.subject.other | cancer | |
dc.subject.other | hepcidin | |
dc.subject.other | patient blood management | |
dc.subject.other | malaria | |
dc.subject.other | iron deficiency | |
dc.subject.other | hepcidin | |
dc.subject.other | TNF | |
dc.subject.other | children | |
dc.subject.other | Africa | |
dc.subject.other | Anemia | |
dc.subject.other | iron deficiency | |
dc.subject.other | oral iron salts | |
dc.subject.other | intravenous iron | |
dc.subject.other | Sucrosomial® iron | |
dc.subject.other | M cells | |
dc.subject.other | bioavailability | |
dc.subject.other | tolerability | |
dc.subject.other | efficacy | |
dc.subject.other | iron | |
dc.subject.other | gut microbiota | |
dc.subject.other | iron supplementation | |
dc.subject.other | iron transporters | |
dc.subject.other | mucosal immunity | |
dc.subject.other | SCFA | |
dc.subject.other | intestinal inflammation | |
dc.subject.other | inflammatory bowel disease (IBD) | |
dc.subject.other | colorectal cancer | |
dc.subject.other | oxidative stress | |
dc.subject.other | anaemia | |
dc.subject.other | cardiovascular disease | |
dc.subject.other | chronic kidney disease | |
dc.subject.other | IV iron therapy | |
dc.subject.other | bone homeostasis | |
dc.subject.other | iron overload | |
dc.subject.other | iron deficiency | |
dc.subject.other | osteoclast | |
dc.subject.other | osteoblast | |
dc.subject.other | osteoporosis | |
dc.subject.other | neurodegeneration with brain iron accumulation | |
dc.subject.other | iron chelation therapy | |
dc.subject.other | multifunctional iron chelators | |
dc.subject.other | fluorescent iron chelator | |
dc.subject.other | 3-hydroxy-4-pyridinone | |
dc.subject.other | fluorophore | |
dc.subject.other | rhodamine | |
dc.subject.other | membrane interactions | |
dc.subject.other | bacteria | |
dc.subject.other | antibacterial activity | |
dc.subject.other | histidine | |
dc.subject.other | iron | |
dc.subject.other | anemia | |
dc.subject.other | oxidative stress | |
dc.subject.other | kidney | |
dc.subject.other | chelation | |
dc.subject.other | iron | |
dc.subject.other | retina | |
dc.subject.other | age-related macular degeneration (AMD) | |
dc.subject.other | iron | |
dc.subject.other | lipid | |
dc.subject.other | obesity | |
dc.subject.other | cancer | |
dc.subject.other | neurodegeneration | |
dc.subject.other | iron chelation | |
dc.subject.other | phlebotomy | |
dc.subject.other | NCOA4 | |
dc.subject.other | ferritinophagy | |
dc.subject.other | iron homeostasis | |
dc.subject.other | erythropoiesis | |
dc.subject.other | ferroptosis | |
dc.subject.other | cancer | |
dc.subject.other | Tfr2 | |
dc.subject.other | iron metabolism | |
dc.subject.other | hepcidin | |
dc.subject.other | erythropoiesis | |
dc.subject.other | SNC | |
dc.subject.other | ferritin | |
dc.subject.other | iron mobilization | |
dc.subject.other | chaotropes | |
dc.subject.other | flavin nucleotide | |
dc.subject.other | electron transfer | |
dc.subject.other | kinetics | |
dc.subject.other | ferritin | |
dc.subject.other | iron | |
dc.subject.other | iron delivery | |
dc.subject.other | nanotechnology | |
dc.subject.other | nanocage | |
dc.subject.other | drug delivery | |
dc.subject.other | inflammation | |
dc.subject.other | serum biomarker | |
dc.subject.other | iron metabolism | |
dc.subject.other | hepcidin | |
dc.subject.other | ferroportin | |
dc.subject.other | hemochromatosis | |
dc.subject.other | anemia | |
dc.subject.other | hepcidin | |
dc.subject.other | iron deficiency anemia | |
dc.subject.other | iron dextran | |
dc.subject.other | neonatal period | |
dc.subject.other | pig | |
dc.subject.other | supplementation | |
dc.subject.other | Alzheimer’s disease | |
dc.subject.other | neuroinflammation | |
dc.subject.other | neurodegeneration | |
dc.subject.other | cytokines | |
dc.subject.other | neuroimmune responses | |
dc.subject.other | iron | |
dc.subject.other | genetic hemochromatosis | |
dc.subject.other | non transferrin bound iron | |
dc.subject.other | hepcidin | |
dc.subject.other | ferroportin | |
dc.subject.other | venesections | |
dc.subject.other | Anemia of chronic disease | |
dc.subject.other | anemia of inflammation | |
dc.subject.other | hepcidin | |
dc.subject.other | anti-hepcidin therapy | |
dc.subject.other | iron supplementation | |
dc.subject.other | macrophage | |
dc.subject.other | central nurse macrophage | |
dc.subject.other | red pulp macrophage | |
dc.subject.other | Kupffer cell | |
dc.subject.other | iron metabolism | |
dc.subject.other | erythropoiesis | |
dc.subject.other | erythroblastic islands | |
dc.subject.other | erythrophagocytosis | |
dc.subject.other | inflammation | |
dc.subject.other | iron homeostasis | |
dc.subject.other | lung diseases | |
dc.subject.other | oxygen sensing | |
dc.subject.other | hypoxia | |
dc.subject.other | ferritin | |
dc.subject.other | hereditary hyperferritinemia | |
dc.subject.other | hereditary hypoferritinemia | |
dc.subject.other | iron metabolism | |
dc.subject.other | cataracts syndrome | |
dc.subject.other | neurodegenerative disease | |
dc.subject.other | n/a | |
dc.subject.other | iron | |
dc.subject.other | neurodegeneration | |
dc.subject.other | NBIA | |
dc.subject.other | hepcidin | |
dc.subject.other | iron | |
dc.subject.other | lung | |
dc.subject.other | acute lung injury | |
dc.subject.other | COPD | |
dc.subject.other | lung infection | |
dc.subject.other | cystic fibrosis | |
dc.subject.other | iron | |
dc.subject.other | anaemia | |
dc.subject.other | infection | |
dc.subject.other | malaria | |
dc.subject.other | immunity | |
dc.subject.other | brain development | |
dc.subject.other | growth | |
dc.subject.other | microbiome | |
dc.subject.other | hepcidin | |
dc.subject.other | ferritin | |
dc.subject.other | iron supplementation | |
dc.subject.other | infants | |
dc.subject.other | children | |
dc.subject.other | low and middle income countries | |
dc.subject.other | liver | |
dc.subject.other | iron | |
dc.subject.other | hepcidin | |
dc.subject.other | Mek/Erk | |
dc.subject.other | Hfe | |
dc.subject.other | Bmp/Smad | |
dc.subject.other | iron | |
dc.subject.other | mycobacteria | |
dc.subject.other | immunity | |
dc.subject.other | Alzheimer’s disease | |
dc.subject.other | iron homeostasis | |
dc.subject.other | ferroptosis | |
dc.subject.other | senescence | |
dc.subject.other | chelators | |
dc.subject.other | macrophages | |
dc.subject.other | iron | |
dc.subject.other | metabolism | |
dc.subject.other | inflammation | |
dc.subject.other | iron | |
dc.subject.other | ferritin | |
dc.subject.other | acute kidney injury | |
dc.subject.other | chronic kidney disease | |
dc.subject.other | vascular calcification | |
dc.subject.other | iron | |
dc.subject.other | hepcidin | |
dc.subject.other | ferroportin | |
dc.subject.other | Interleukin-6 | |
dc.subject.other | infection | |
dc.subject.other | rheumatoid arthritis | |
dc.subject.other | iron homeostasis | |
dc.subject.other | iron absorption | |
dc.subject.other | non-haem iron | |
dc.subject.other | flavonoids | |
dc.subject.other | developmental | |
dc.subject.other | iron deficiency anemia | |
dc.subject.other | neonatal | |
dc.subject.other | transferrin receptor | |
dc.subject.other | treatment | |
dc.subject.other | hemochromatosis | |
dc.subject.other | HFE | |
dc.subject.other | natural history | |
dc.subject.other | T lymphocytes | |
dc.subject.other | MHC | |
dc.subject.other | CD8+ T cells | |
dc.subject.other | prevention | |
dc.subject.other | iron homeostasis | |
dc.subject.other | hepcidin | |
dc.subject.other | protein binding | |
dc.subject.other | peritoneal dialysis | |
dc.subject.other | iron | |
dc.subject.other | hepcidin | |
dc.subject.other | iron regulatory proteins | |
dc.subject.other | cardiomyocyte | |
dc.subject.other | chronic heart failure | |
dc.subject.other | pulmonary arterial smooth muscle cells | |
dc.subject.other | pulmonary arterial hypertension | |
dc.subject.other | iron | |
dc.subject.other | brain | |
dc.subject.other | neurophysiology | |
dc.subject.other | cognition | |
dc.subject.other | social behavior | |
dc.subject.other | didox | |
dc.subject.other | iron chelators | |
dc.subject.other | antitumor compound | |
dc.subject.other | iron metabolism | |
dc.subject.other | RRM2 | |
dc.subject.other | SLC40A1 | |
dc.subject.other | ferroportin | |
dc.subject.other | iron overload | |
dc.subject.other | non-HFE | |
dc.subject.other | ferritin | |
dc.subject.other | hemochromatosis | |
dc.subject.other | iron | |
dc.subject.other | chelation | |
dc.subject.other | neurodegenerative diseases | |
dc.subject.other | pituitary | |
dc.subject.other | brain | |
dc.subject.other | hemopexin | |
dc.subject.other | heme homeostasis | |
dc.subject.other | iron homeostasis | |
dc.subject.other | hemolysis | |
dc.subject.other | haptoglobin | |
dc.subject.other | ferroptosis | |
dc.subject.other | inflammation | |
dc.subject.other | biomarker | |
dc.subject.other | heme oxygenase | |
dc.subject.other | liver | |
dc.subject.other | microbiome | |
dc.subject.other | trauma | |
dc.subject.other | hemorrhage | |
dc.subject.other | iron metabolism | |
dc.subject.other | hepcidin | |
dc.subject.other | iron homeostasis | |
dc.subject.other | ferroportin | |
dc.subject.other | n/a | |
dc.title | Peer Review, Peer Education, and Modeling in the Practice of Clinical Ethics Consultation: The Zadeh Project | |
dc.type | 電子教科書 | |
dc.classification | 醫學類 | |
Theme: | 教科書-醫學類 |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.